WallStreetZenWallStreetZen

NASDAQ: KNSA
Kiniksa Pharmaceuticals International PLC Stock Ownership - Who owns Kiniksa Pharmaceuticals International?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kiniksa Pharmaceuticals International PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ross MoatCHIEF OPERATING OFFICER2026-04-091,703$46.69
$79.51kSell
Michael R. MegnaCHIEF ACCOUNTING OFFICER2026-04-096,625$46.69
$309.32kSell
Ross MoatCHIEF OPERATING OFFICER2026-04-07774$48.94
$37.88kSell
John F. PaoliniCHIEF MEDICAL OFFICER2026-04-071,208$48.94
$59.12kSell
Michael R. MegnaCHIEF ACCOUNTING OFFICER2026-04-071,666$48.94
$81.53kSell
Sanj K. PatelCHAIRMAN CEO2026-04-074,831$48.94
$236.43kSell
Eben TessariCHIEF STRATEGY OFFICER2026-04-07846$48.94
$41.40kSell
Mark RagosaCHIEF FINANCIAL OFFICER2026-04-071,303$48.94
$63.77kSell
Michael R. MegnaCHIEF ACCOUNTING OFFICER2026-04-073,932$1.00
$3.93kBuy
Ross MoatCHIEF OPERATING OFFICER2026-04-062,367$48.58
$114.99kSell

1 of 21

KNSA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KNSA insiders and whales buy or sell their stock.

KNSA Shareholders

What type of owners hold Kiniksa Pharmaceuticals International PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rubric Capital Management LP4.35%3,328,653$142.43MInstitution
Vanguard Group Inc4.07%3,112,937$133.20MInstitution
Baker Bros Advisors LP3.69%2,826,246$120.94MInstitution
Baker Bros Advisors LP3.60%2,753,656$117.83MInsider
Tang Capital Management LLC2.95%2,259,889$96.70MInstitution
Cormorant Asset Management LP2.26%1,731,442$74.09MInsider
Acadian Asset Management LLC2.24%1,713,043$73.30MInstitution
Fmr LLC2.15%1,642,863$70.30MInstitution
Morgan Stanley1.78%1,360,044$58.20MInstitution
Fairmount Funds Management LLC1.72%1,319,688$56.47MInstitution

1 of 3

KNSA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KNSA56.15%9.32%Net SellingNet Selling
LQDA50.07%49.93%Net SellingNet Selling
EWTX88.61%11.39%Net SellingNet Selling
GPCR31.36%10.38%Net SellingNet Selling
NAMS74.47%25.53%Net SellingNet Selling
View Top Biotech Stocks

Kiniksa Pharmaceuticals International Stock Ownership FAQ

Who owns Kiniksa Pharmaceuticals International?

Kiniksa Pharmaceuticals International (NASDAQ: KNSA) is owned by 56.15% institutional shareholders, 9.32% Kiniksa Pharmaceuticals International insiders, and 34.54% retail investors. Baker Bros Advisors LP is the largest individual Kiniksa Pharmaceuticals International shareholder, owning 2.75M shares representing 3.60% of the company. Baker Bros Advisors LP's Kiniksa Pharmaceuticals International shares are currently valued at $120.09M.

If you're new to stock investing, here's how to buy Kiniksa Pharmaceuticals International stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.